{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidtc6okqww6j2xm6nzrkha4lfokgsqg555kn64ukvjuna6ixse2zu",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mgmwvkj7btz2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicawrklm2fn2hrga6ijgd6zgevr32h3xaitqxjqo77zgbkqjzfkxe"
    },
    "mimeType": "image/jpeg",
    "size": 80988
  },
  "path": "/2026/03/08/vinay-prasad-fda-lessons-from-tenure/?utm_campaign=rss",
  "publishedAt": "2026-03-08T15:10:03.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Matt's Take",
    "Politics",
    "biotechnology",
    "drug development",
    "FDA",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "Vinay Prasad's unique ability to attract criticism — even when his bosses, including the president, wanted him to keep his head low — did him in at the FDA.",
  "title": "STAT+: 5 lessons from Vinay Prasad’s turbulent tenure at the FDA",
  "updatedAt": "2026-03-08T15:53:25.000Z"
}